January 21, 2018 / 11:36 PM / 7 months ago

BRIEF-Symbio Pharmaceuticals ‍initiated Phase 1 Study in Japan for Oral Treakisym in patients with progressive solid tumors​

Jan 21 (Reuters) - Symbio Pharmaceuticals Ltd:

* ‍HAS INITIATED A PHASE 1 STUDY IN JAPAN FOR ORAL TREAKISYM IN PATIENTS WITH PROGRESSIVE SOLID TUMORS​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below